Home Infusion Therapy Insurance Denied? How to Fight Site-of-Care Denials
Insurers redirect patients from home infusion to hospital-based centers for IVIG, biologics, and vancomycin. Here's how to appeal site-of-care steering decisions.
Home Infusion Therapy Insurance Denied? How to Fight Site-of-Care Denials
Home infusion therapy allows patients to receive intravenous medications — antibiotics, immunoglobulin, chemotherapy, biologics — in their own homes rather than traveling to a hospital infusion center or clinic. For stable, clinically appropriate patients, home infusion is safe, less expensive, and significantly better for quality of life. Insurers know this — which makes it all the more frustrating when they deny home infusion and redirect patients to higher-cost institutional settings that serve the insurer's contracting interests.
What Is Site-of-Care Steering?
Site-of-care steering occurs when an insurer approves a medication but denies the requested home infusion setting, requiring the patient to receive the same drug at a hospital outpatient infusion center or ambulatory infusion suite. Ostensibly this is framed as a patient safety policy. In practice, it often reflects contractual relationships with hospital systems and the insurer's own financial arrangements.
Site-of-care denials are among the most contested in home infusion because the clinical argument for home infusion is often strong: the patient is stable, the medication is well-established in the home setting, and a licensed home infusion pharmacy and nursing service is available and qualified.
Common Drugs Denied for Home Infusion
IVIG (intravenous immunoglobulin). Used for primary immunodeficiency, CIDP, myasthenia gravis, and dermatomyositis, among other conditions. Home IVIG is standard of care for stable patients on established dosing. Denials often occur on first authorization and after plan year resets.
Vancomycin and other IV antibiotics. Outpatient parenteral antibiotic therapy (OPAT) programs for serious infections like osteomyelitis, endocarditis, and SSTI are well-established and guideline-supported. The IDSA (Infectious Diseases Society of America) publishes specific OPAT guidelines supporting home administration for appropriate candidates.
Subcutaneous immunoglobulin (SCIG). SCIG is an alternative to IVIG that patients can self-administer at home after training. Some insurers deny SCIG and require IVIG at a center, ignoring that SCIG has a strong safety and efficacy record and better quality-of-life outcomes for many patients.
Biologics via IV infusion. Infliximab (Remicade), natalizumab (Tysabri), and other biologics have established home infusion protocols. Some payers require these be given at infusion centers regardless of patient stability.
Total parenteral nutrition (TPN). Home TPN for patients with short bowel syndrome or gastrointestinal failure is medically well-supported. Denials occur over provider credentials, nursing visit frequency, and formulary composition.
ClaimBack generates a professional appeal letter in 3 minutes — citing real insurance regulations for your country. Get your free analysis →
How to Appeal a Home Infusion Denial
Challenge the site-of-care policy directly. Request a copy of the insurer's site-of-care policy in writing. Many of these policies are applied inconsistently and may not meet state insurance requirements for medical necessity determination.
Document clinical appropriateness for home setting. Your prescribing physician should provide a letter stating that the patient is clinically stable, has a caregiver available if needed, has appropriate venous access, and has been trained or will be trained on the infusion protocol. Reference clinical guidelines (IDSA for antibiotics, AAAAI for IVIG in immunodeficiency) that support home administration.
Demonstrate cost neutrality or savings. Home infusion is typically less expensive than hospital infusion centers. If your insurer is steering you to a more expensive setting, document this disparity. Some states have regulations preventing insurers from requiring more expensive settings when a less costly setting is clinically safe.
Involve the home infusion pharmacy. Accredited home infusion pharmacies (ACHC or URAC accredited) have dedicated reimbursement staff and can provide clinical documentation, nursing assessments, and Prior Authorization Denied: How to Appeal" class="auto-link">prior authorization support. Leverage their expertise.
Request peer-to-peer review. The prescribing physician should request a peer-to-peer call with the insurer's medical director. Physicians who are active in home infusion and can cite clinical guidelines are highly effective in these calls.
File a state insurance complaint. If site-of-care steering appears to be a blanket policy rather than an individualized medical necessity determination, this may violate state insurance regulations requiring that medical necessity decisions be made on an individual basis. State insurance commissioners have taken enforcement action against payers for systematic site-of-care steering.
The No Surprises Act and Home Infusion
The No Surprises Act (effective January 2022) includes protections against certain unexpected billing practices, but does not directly address site-of-care steering. However, it does affect balance billing in some infusion contexts. If you have been redirected to an out-of-network infusion center, review your rights under applicable balance billing protections.
Fight Back With ClaimBack
ClaimBack helps home infusion patients build detailed, clinically credible appeals that address site-of-care arguments head-on. Our platform generates letters that cite the right guidelines, safety data, and payer policy language.
Start your home infusion appeal now
Related Reading
How much did your insurer deny?
Enter your denied claim amount to see what you could recover.
Your insurer is counting on you giving up.
Most people do. Less than 1% of denied claimants ever appeal — even though the majority who do win. ClaimBack was built by people who were denied, who fought back, and who refused to accept "no" from an insurer.
We give you the same appeal arguments that attorneys use — in 3 minutes, for free. Your denial deadline is ticking. Don't let it expire.
Free analysis · No credit card · Takes 3 minutes
Related ClaimBack Guides